North America Non-vascular Stents Market Size & Outlook, 2030

Revenue, 2023 (US$M)

$713.5

Forecast, 2030 (US$M)

$974.7

CAGR, 2024 - 2030

4.6%

Report Coverage

North America

North America non-vascular stents market, 2018-2030 (US$M)

Unlock Premium

Related Markets

Global Non-vascular Stents Industry Outlook

Europe Non-vascular Stents Market Outlook

Asia Pacific Non-vascular Stents Market Outlook

Latin America Non-vascular Stents Market Outlook

MEA Non-vascular Stents Market Outlook

North America non-vascular stents market highlights

The North America non-vascular stents market generated a revenue of USD 713.5 million in 2023.
The market is expected to grow at a CAGR of 4.6% from 2024 to 2030.
In terms of segment, gastrointestinal stents was the largest revenue generating type in 2023.
Gastrointestinal Stents is the most lucrative type segment registering the fastest growth during the forecast period.

North America data book summary

Market revenue in 2023	USD 713.5 million
Market revenue in 2030	USD 974.7 million
Growth rate	4.6% (CAGR from 2023 to 2030)
Largest segment	Gastrointestinal stents
Fastest growing segment	Gastrointestinal Stents
Historical data covered	2018 - 2022
Base year for estimation	2023
Forecast period covered	2024 - 2030
Quantitative units	Revenue in USD million
Market segmentation	Gastrointestinal Stents
Key market players worldwide	Medtronic PLC, BD, Boston Scientific Corp, Conmed Corp, Hobbs Medical, COOK, Glaukos Corp

Other key industry trends

In terms of revenue, North America region accounted for 43.7% of the global non-vascular stents market in 2023.
Globally, North America is projected to lead the regional market in terms of revenue in 2030.
Asia Pacific is the fastest growing regional market and is projected to reach USD 519.4 million by 2030.

No credit card required*

Horizon in a snapshot

30K+ Global Market Reports
120K+ Country Reports
1.2M+ Market Statistics
200K+ Company Profiles
Industry insights and more

Non-vascular Stents Market Scope

Non-vascular stents market segmentation & scope

Type

Gastrointestinal Stents

Biliary

Duodenal

Colonic

Pancreatic

Esophageal Stents

Pulmonary (Airway) Stents

Silicone Airway

Metallic Airway

Urological Stents

Others

End Use

Hospitals

Ambulatory Care Centers (ACS)

Specialty Clinics

Regions

Latin America

Europe

North America

Middle East & Africa

Asia Pacific

Countries

U.S.

Canada

Mexico

Sweden

Spain

Norway

Italy

Germany

France

Denmark

Brazil

Argentina

Australia

China

India

Japan

South Korea

Thailand

UAE

South Africa

Saudi Arabia

Kuwait

Non-vascular Stents Market Companies

Name	Profile	# Employees	HQ	Website

North America non-vascular stents market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to non-vascular stents market will help companies and investors design strategic landscapes.

Gastrointestinal stents was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America non-vascular stents market based on gastrointestinal stents covering the revenue growth of each sub-segment from 2018 to 2030.

North America Non-vascular Stents Type Outlook (Revenue, USD Million, 2018-2030)
- Gastrointestinal Stents
  - Biliary
  - Duodenal
  - Colonic
  - Pancreatic
  - Esophageal Stents
- Pulmonary (Airway) Stents
  - Silicone Airway
  - Metallic Airway
- Urological Stents
- Others
North America Non-vascular Stents End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Ambulatory Care Centers (ACS)
- Specialty Clinics

Reasons to subscribe to North America non-vascular stents market databook:

Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America non-vascular stents market databook

Our clientele includes a mix of non-vascular stents market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America non-vascular stents market , including forecasts for subscribers. This continent databook contains high-level insights into North America non-vascular stents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list